Skip to Content
Merck
CN
All Photos(1)

Documents

260215

Sigma-Aldrich

1,2-Epoxyhexadecane

technical grade, 85%

Sign Into View Organizational & Contract Pricing
All Photos(1)
Empirical Formula (Hill Notation):
C16H32O
CAS Number:
7320-37-8
Molecular Weight:
240.42
EC Number:
230-786-2
MDL number:
MFCD00005151
UNSPSC Code:
12162002
PubChem Substance ID:
24855727
NACRES:
NA.23

grade

technical grade

Assay

85%

refractive index

n20/D 1.446 (lit.)

bp

175-180 °C/12 mmHg (lit.)

mp

21-22 °C (lit.)

density

0.846 g/mL at 25 °C (lit.)

storage temp.

2-8°C

SMILES string

CCCCCCCCCCCCCCC1CO1

InChI

1S/C16H32O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-15-17-16/h16H,2-15H2,1H3

InChI key

DSZTYVZOIUIIGA-UHFFFAOYSA-N

Pictograms

Exclamation mark
GHS07

Signal Word

Warning

Hazard Statements

H315,H319,H335,H413

Hazard Classifications

Aquatic Chronic 4 - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

WGK

WGK 2

Flash Point(F)

199.4 °F

Flash Point(C)

93 °C

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Shantipriya Khadka et al.
Electrophoresis, 37(23-24), 3160-3171 (2016-09-10)
A novel precursor monolithic capillary column referred to as "hydroxy monolith" or OHM was prepared by the in situ copolymerization of hydroxyethylmethacrylate (HEMA) with pentaerythritol triacrylate (PETA) yielding the neutral poly(HEMA-co-PETA) monolith. The neutral precursor OHM capillary thus obtained was
Khalid A Hajj et al.
Nano letters, 20(7), 5167-5175 (2020-06-05)
The clinical translation of messengerRNA (mRNA) drugs has been slowed by a shortage of delivery vehicles that potently and safely shuttle mRNA into target cells. Here, we describe the properties of a particularly potent branched-tail lipid nanoparticle that delivers mRNA
Rachel S Riley et al.
Science advances, 7(3) (2021-02-02)
Clinical advances enable the prenatal diagnosis of genetic diseases that are candidates for gene and enzyme therapies such as messenger RNA (mRNA)-mediated protein replacement. Prenatal mRNA therapies can treat disease before the onset of irreversible pathology with high therapeutic efficacy

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service